RT @RichardPAConway: Deodhar et al. Bimekizumab (IL-17A/Fi) in nr-axSpA. Efficacy shown across all outcomes. Confirms bi

Social Author Image

https://pbs.twimg.com/profile_images/1389468430160510976/sooz0Ud3.jpg

Tweet Author

Social Author Name

Richard Conway

Tweet Content

Deodhar et al. Bimekizumab (IL-17A/Fi) in nr-axSpA. Efficacy shown across all outcomes. Confirms bimekizumab works across spectrum of axSpA (not surprisingly). @RheumNow #ACR22 Abstr#0544 https://t.co/XVGBgBQpTH https://t.co/39zW5Ex9xh

Links

Bimekizumab Improves Signs and Symptoms, Including Inflammation, in Patients wi… https://acrabstracts.org/abstract/bimekizumab-improves-signs-and-symptoms-inclu…

Show on Archive Page

On

Display in Search Results

On

PDQ

Off

Topics

RT @RichardPAConway: Deodhar et al. Bimekizumab (IL-17A/Fi) in nr-axSpA. Efficacy shown across all outcomes. Confirms bi

Do you get our email newsletter?